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Nuclear protein turnoverDiligent balance of nuclear factor kappa B (NF-κB) activity is essential owing to NF-κB's decisive role in cellular
processes including inﬂammation, immunity and cell survival. Ubiquitin/proteasome-system (UPS)-dependent
degradation of activated NF-κB/RelA involves the cullin-RING-ubiquitin-ligase (CRL) ECSSOCS1. The COP9
signalosome (CSN) controls ubiquitin (Ub) ligation by CRLs through the removal of the CRL-activating Ub-like
modiﬁer NEDD8 from their cullin subunits and through deubiquitinase (DUB) activity of associated DUBs. How-
ever, knowledge about DUBs involved in the regulation of NF-κB activity within the nucleus is scarce.
In this study we observed that USP48, a DUB of hitherto ill-deﬁned function identiﬁed through a siRNA screen,
associates with the CSN and RelA in the nucleus.We show that USP48 trims rather than completely disassembles
long K48-linked free and substrate-anchored Ub-chains, a catalytic property only shared with ataxin-3 (Atx3)
and otubain-1 (OTU1), and that USP48 Ub-chain-trimming activity is regulated by casein-kinase-2 (CK2)-
mediated phosphorylation in response to cytokine-stimulation. Functionally, we demonstrate for the ﬁrst
time the CSN and USP48 to cooperatively stabilize the nuclear pool of RelA, thereby facilitating timely induction
and shutoff of NF-κB target genes.
In summary, this study demonstrates that USP48, a nuclear DUB regulated by CK2, controls the UPS-dependent
turnover of activated NF-κB/RelA in the nucleus together with the CSN. Thereby USP48 contributes to a timely
control of immune responses.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The ubiquitous transcription factor NF-κB has a decisive function in
innate and adaptive immune responses, proliferation and differentia-
tion. Tight control of NF-κB activity is essential to prevent persistent
tissue damage by chronic inﬂammation, representing one major factor
contributing to cancer development [1].
The RelA/p50 complex is the prototypic dimeric transcription factor
within the NF-κB family. NF-κB is retained in the cytosol by association
with inhibitors of NF-κB (IκBs), exempliﬁed by the prototypic family
member IκBα, which covers the nuclear localization sequence (NLS)
of RelA [2]. In response to various stimuli, initiating the classical path-
way of NF-κB activation, IκBα becomes sequentially phosphorylated,
ubiquitinated and degraded by the 26S proteasome, resulting in release
of NF-κB, its nuclear translocation and ultimately induction of NF-κB
target genes. Among the latter is iκbα and reaccumulation of IκBαrsity, Medical Faculty, Institute
39120 Magdeburg, Germany.
n).protein represents one major negative feedback loop warranting
efﬁcient termination of NF-κB activity through IκBα-dependent nuclear
export of RelA [2]. Another importantmechanismcontributing to timely
termination of NF-κB activity is UPS-dependent degradation of RelA in
the nucleus/on chromatin [3]. An Ub ligase (Ub-E3) targeting TNF-
activated nuclear RelA for degradation is the CRL ECSSOCS1, composed
of cullin-2 (Cul2), the adapter proteins Elongin (Elo) B and C, the sub-
strate recognition molecule SOCS1 and the accessory substrate adapter
protein “copper metabolism Murr1 domain-containing protein 1”
(COMMD1) [4,5].
A superposed regulator of CRLs is the eight subunit (CSN1-8) CSN
complex, conserved in the genomes of all eukaryotes [6], which impacts
on NF-κB signal transmission at various stages and in response to differ-
ent triggers [7]. After TNF stimulation, the CSN transiently associates
with de novo synthesized IκBα to facilitate its reaccumulation and pro-
tect it from sustained UPS-dependent degradation [8]. Upon T cell acti-
vation by TCR/CD28 ligation, the CSN associateswith the Carma1-Bcl10-
Malt1 (CBM) complex, to support efﬁcient activation of the IκB kinase
(IKK) complex [9]. Due to a JAB1/MPN/MOV34 (JAMM/MPN+) motif
in CSN5, the CSN, but not isolated CSN5, possesses NEDD8 peptidase
(deneddylase) activity [6]. Apart from this, the CSN exerts DUB activity
through the association with DUBs, e.g. USP15 [10–12]. Reversible
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cullins and Parc, is a critical step in the regulation of CRL assembly and
catalytic activity, as well as the proteolytic turnover of CRL subunits
[12,13]. While substrate recruitment and cullin neddylation promote
CRL activation and substrate ubiquitination, the CSN inhibits CRL
activity in vitro. However, since the CSN, through its catalytic activities,
protects CRL subunits from autocatalytic degradation [12,14,15] and,
independent of its catalytic activities, sequesters fully assembled CRLs,
holding them ready in a low activity but immediately accessible state
[16], according to the prevailingmodel [17,18], the CSN is predominant-
ly viewed as positive regulator of the UPS in vivo.
The human genome encodes close to 100 DUBs, which can be
subdivided into ﬁve families, Ub C-terminal hydrolases (UCHs), Ub-
speciﬁc peptidases (USPs), ovarian tumor proteases (OTUs), Machado–
Joseph disease proteases (MJDs) and JAMM/MPN+ proteases. The ﬁrst
four families belong to the cysteine proteases, whereas JAMM/MPN+
family members are zinc-dependent metalloproteases [19]. While vari-
ous DUBs from different families participate in the regulation of up-
stream signaling cascades leading to NF-κB activation [20], knowledge
about DUBs involved in the regulation of NF-κB/RelA in the nucleus is
scarce. In the present study we show for the ﬁrst time that the CSN
and USP48, a DUB of hitherto largely unknown function, cooperate in
the control of ECSSOCS1-dependent RelA ubiquitination to ensure timely
induction and shutoff of NF-κB target genes.
2. Results
2.1. RelA and CSN interact in the nucleus
Aiming to explore a potential impact of the CSN on the nuclear turn-
over of RelA, we initially studied its TNF-induced ubiquitination in sub-
cellular fractions of HeLa cells pulse-stimulated with TNF. Following
medium exchange after 15 min, cells were treated with Leptomycin B
(LMB) and MG132 to prevent Crm1-dependent nuclear export and
proteasomal degradation of RelA. Ubiquitinated RelA (RelA-Ub) accu-
mulated in the nucleus from 1 h after stimulation and predominantly
amassed in the insoluble nuclear fraction (N2), enriched for PML and
subunits of the 20S proteasome core (Fig. S1A), after 2 h and 4 h
(Fig. 1A). Notably, immunoprecipitations (IPs) of RelA from N2 were
performed under denaturing conditions, precluding co-IP of associated
ubiquitinated proteins. RelA predominantly resided in the cytosol in
non-stimulated cells, but translocated into the soluble nuclear fraction
(N1) in response to TNF, showing the highest accumulation after
30 min, when IκBα was almost completely degraded in the cytosol.
The decline of RelA inN1 from1h after stimulation and the concomitant
lack of RelA enrichment inN2are due to accumulation of highmolecular
weight (HMW) RelA-Ub. Interestingly, nuclear accumulation and an in-
creasing co-IP of the CSN (CSN3)with RelAwere concurrently observed
in N1 (Figs. 1A and S1B). Notably, inducible association of the CSN
with factors of the NF-κB system (IκBα, IKKβ, Bcl10), regulated by
CRL- and/or UPS-dependent degradation, has been demonstrated
previously [8,9,21,22].
To display the TNF-induced shift of RelA from N1 to N2, cells were
transiently transfectedwithHis6-T7-RelA. Overexpressed RelA constitu-
tively localized in N1 and did not further accumulate in response to TNF
(Fig. 1B).Moreover, degradation of IκBαwas not detectable in the cytosol
of RelA-transfected cells due to constitutive NF-κB activity and induction
of IκBα de novo synthesis, indicated by strongly increased basal expres-
sion of IκBα. In spite of this, TNF induced a movement of His6-T7-RelA
from N1 to N2, where it, continuously expressed under the control of
the CMV promoter, accumulated. Simultaneously, His6-T7-RelA-Ub
amassed almost exclusively in N2 alike, most prominently at late times
(Fig. 1B), consistent with data obtained for endogenous RelA (Fig. 1A).
There it was detected by antibodies speciﬁc for Ub or K48-linked
Ub-chains, indicating that ubiquitination labels RelA for degradation
via the UPS.Studying nuclear turnover of endogenous RelA in the presence of
LMB but the absence of MG132, repetitive RelA nuclear translocation
and RelA-Ub accumulation were observed in N2. Yet, 1 h and 4 h after
TNF stimulation RelA-Ub was lost from N2 due to UPS-dependent
degradation (Fig. 1C). Renewed accumulation and ubiquitination of
RelA in N2 2 h after stimulation is likely due to a second wave of NF-
κB activation, even after the single pulse of TNF applied in the experi-
ment. Inherent oscillatory properties of the NF-κB system after its
activation by TNF and other stimuli through e.g. induction of both,
pro-inﬂammatory cytokines, as well as negative regulators (IκBs and
the DUB A20) have been reported and their biological signiﬁcance
in control of NF-κB-dependent gene induction is subject of debate
[23–25]. Like in the previous experiment, RelA-Ub was recognized by
antibodies speciﬁc for Ub or K48-linked Ub-chains. Interestingly, in
the absence of MG132, strongest RelA ubiquitination was observed
already at an earlier time (10min), indicating that subsequent to its nu-
clear entry RelA becomes rapidly ubiquitinated. Notably, TNF-induced
RelA ubiquitination in the nucleus was similarly observed in HEK293
cells (Fig. S1C).
2.2. CSN and ECSSOCS1 control RelA ubiquitination and nuclear abundance/
turnover
To analyze the impact of the CSN and ECSSOCS1 on RelA ubiquitination,
we performed transient knockdowns of CSN2 and the ECSSOCS1 subunits
COMMD1 and EloB. Target-speciﬁc knockdown of CSN2 (Fig. S2A)
destabilized the CSN complex (Fig. S2B). Concerted modulation of
CSN subunit protein expression is in agreement with previous reports
[8,26–28]. In response to TNF in the presence of MG132, RelA-Ub accu-
mulation was enhanced in CSN-depleted cells (Fig. 2A), indicating that
the CSN antagonizes ubiquitination of RelA. On the contrary, in cells
depleted for either COMMD1 or EloB (Fig. 2B, C), RelA ubiquitination
was decreased/nearly abolished, consistent with ECSSOCS1 being the
predominant Ub-E3 for RelA, as suggested previously [4,5]. Studying
the impact of the CSN on nuclear abundance and turnover of RelA in
TNF-stimulated cells, we observed RelA nuclear accumulation to be de-
layed and diminished up to 60 min in CSN2-depleted cells, when it
peaked in N1. Yet, 2 h and 4 h after stimulation, the clearance of RelA
from N1 in the presence of LMB was enhanced (Fig. 2D). In EloB knock-
down cells deﬁcient for functional ECSSOCS1 in contrast, basal and TNF-
induced nuclear accumulation of RelA were enhanced (Fig. 2E). More
importantly however, the depletion of RelA from the nucleus, visible
from 30min after TNF stimulation, was diminished, consistent with im-
paired RelA ubiquitination and UPS-dependent degradation. Instead of
efﬁcient clearance from the nucleus, a movement of RelA from N1 to
N2 was observed (Fig. 2E).
2.3. CSN directly interacts with RelA and USP48
To identify DUBs counteracting TNF-induced ubiquitination and
degradation of nuclear RelA, a siRNA screen was performed, from
which USP48 (formerly USP31) [29], a biochemically and function-
ally largely uncharacterized DUB, emerged as the most promising
candidate. Structurally it comprises an N-terminal catalytic domain,
three “domains in USPs” (DUSP domains) of unknown function and
a C-terminal Ub-like (UBL) domain (Fig. 3G) [30]. Validating this
DUB candidate, which had already been linked to NF-κB in one previous
study [29], we observed that USP48 predominantly resides in the
nucleus (N1) (Fig. S3A, B), where it constitutively co-precipitated with
the CSN (Fig. 3A, B). TNF-inducible interactions in contrast occurred
between USP48 and RelA (Fig. 3B, C) and between RelA and CSN
(Fig. 3A, C), likewise in N1. Control-IPs without IP antibody did not pre-
cipitate the analyzed proteins (data not shown). Co-IPs between human
puriﬁed CSN, recombinant RelA and recombinant full length USP48
(USP48-FL) revealed direct interactions between CSN and USP48
(Fig. 3D) and between CSN and RelA (Fig. 3E) but not between USP48
Fig. 1. RelA is ubiquitinated in the nucleus and interacts with the CSN. (A) IP of endogenous RelA from subcellular fractions of HeLa cells 15 min pulse-stimulated with TNF (MG132 and
LMB added after 15min) and harvested at the indicated times in the presence of NEM and OPT. (B) IP of overexpressed epitope-tagged RelA after treatment of cells as described (A). (C) IP
of endogenousRelA after treatment of cells as described (A) in the absence ofMG132. (A–C) IBs of IPs and subcellular fractions fromone representative experiment are shown.Detection of
Tubulin (cytosol), Nucleolin (N1) and Lamin B2 (N2) served as control for fraction purity and equal protein load.
455K. Schweitzer, M. Naumann / Biochimica et Biophysica Acta 1853 (2015) 453–469and RelA (Fig. 3F), even when the co-IP-direction was reversed
(Fig. S3C). Similarly, no direct interaction was detected between RelA
and the USP48 catalytic domain (USP48-CD, aa 1–450) (Fig. S3D). It is
however possible, that TNF-induced ubiquitination of RelA and/or
other yet to be identiﬁed inducible PTMs of RelA, USP48 or unknown
interaction partners are required to mediate this interaction.2.4. USP48 stabilizes nuclear RelA through its DUB activity
Next we explored the impact of USP48 on TNF-dependent RelA
nuclear translocation, ubiquitination and turnover. TNF-induced degra-
dation and reaccumulation of IκBαwere not affected in USP48-depleted
cells (Fig. 4A, D, E), indicating unperturbed upstream signaling to NF-κB
Fig. 2. CSN antagonizes ECSSOCS1-dependent RelA ubiquitination. (A–C) RelA-IP from RIPA lysates after transient knockdown of CSN2 (A), COMMD1 (B) or Elongin B (C). (D, E) Functional
inactivation of CSN (D) or ECSSOCS1 (E) by transient knockdown of CSN2 or Elongin B affects TNF-induced nuclear translocation and turnover of RelA. (A–E) HeLa cells were 15min pulse-
stimulatedwith TNF (MG132and/or LMBadded after 15min) and harvested at the indicated times in thepresence ofNEMandOPT. IBs of IPs, lysates and subcellular fractions, as indicated,
from one representative experiment are shown. Tubulin (cytosol, RIPA lysate), Nucleolin (N1) and Lamin B2 (N2) served as control for fraction purity and/or equal protein load.
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enhanced in HeLa and HEK293 cells (Figs. 4A and S4A). In cells
transiently transfected to overexpress USP48-FL, TNF-induced RelAubiquitination in the nucleus was suppressed. Conversely, cells overex-
pressing supposedly catalytically dead USP48-FL with the predicted
catalytic site Cys converted to Ala (USP48C98A) showed enhanced
Fig. 3. CSN directly interacts with RelA and USP48. (A–C) IPs, as indicated, from subcellular fractions of HeLa cells 15min pulse-stimulatedwith TNF (MG132 and LMB added after 15min)
and harvested at the indicated times in the presence of NEM and OPT. IPs and subcellular fractions were analyzed by IB. The detection of Tubulin (cytosol) and Nucleolin (N1) served as
control for subcellular fraction purity and equal protein load. (D–F) Equal molar amounts of recombinant epitope-tagged proteins or human puriﬁed CSN, as indicated, were coincubated
for 2 h at 4 °C and IPs performed afterwards. Complex formation between coincubated proteins and/or the CSN, as well as protein input were analyzed by IB. (A–F) Results obtained from
one representative experiment are shown. (G) Domain structure of USP48. The catalytic triad, consisting of Cys98, His353 and Asn370, and predicted high score CK2 phosphorylation sites in
the C-term of USP48 are shown. Data stem from Swiss-Prot database and a published report [56]. CK2 phosphorylation site prediction was performed with GPS 2.1 [57].
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indicated that USP48 inhibits TNF-induced RelA ubiquitination
through its DUB activity. An in vitro DUB assay with recombinantUSP48-FL and RelA-Ub, immunoprecipitated from nuclear fractions
of TNF-stimulated cells, as substrate, conﬁrmed the ability of USP48
to (incompletely) disassemble poly-Ub-chains attached to RelA
459K. Schweitzer, M. Naumann / Biochimica et Biophysica Acta 1853 (2015) 453–469(Fig. 4C). Interestingly, overexpressed USP48 promoted RelA nuclear
accumulation 30 min after TNF stimulation independent of catalytic
site Cys C98. At later times however, RelA decreased in USP48C98A-
and mock-transfected cells due to ubiquitination and movement into
the HMW fraction, whereas its amount remained constant in USP48-
FL-transfected cells (Fig. 4B). In USP48-depleted cells, TNF-induced
RelA nuclear accumulation was reduced at early times. From 1.5 h after
stimulation, the clearance of RelA from N1 in the presence of LMB was
accelerated, both likely due to enhanced RelA ubiquitination and
proteasomal degradation (Fig. 4D). Of note, USP48 similarly affected
RelA nuclear accumulation and turnover in response to TNF and IL-1β
(Fig. S4B, D). Enhanced RelA nuclear turnover in USP48-depleted cells
was inhibited by treatment of cells with MG132 (Fig. S4C, E). USP48-
dependent protection of RelA from degradationwas conﬁrmed in exper-
iments with the protein synthesis inhibitor cycloheximide (CHX). While
total amounts of RelA did not change in response to TNF, a decrease of
RelA was observed after co-treatment of cells with CHX from 7 h after
TNF stimulation, which was more prominent in USP48-depleted cells
(Fig. 4E). Apart from this, accelerated induction of apoptosis manifested
in USP48-depleted cells co-treated with TNF and CHX, as evidenced by
accelerated cleavage (activation) of pro-caspases 8 and 3 and caspase
substrate PARP1 (Fig. 4E). Protection of cells against TNF/CHX-induced
apoptosis by USP48 was conﬁrmed in a biochemical assay for activation
of executioner caspases 3 and 7 (Fig. 4F). Caspase activation was efﬁ-
ciently inhibited by cell pre-treatment with pan-caspase inhibitor
ZVAD-fmk (Fig. 4F). Depletion of USP48 by itself did not affect cell prolif-
eration and viability (Fig. 4G). Consistent with diminished TNF-induced
nuclear accumulation and accelerated degradation of RelA in USP48-
depleted cells, induction of NF-κB target gene expression was decreased
and/or delayed, whereas gene expression of rela was unaffected
(Fig. 4H). Notably, diminished induction of tnfaip3 (A20) in USP48-
depleted cells could be conﬁrmed at the protein level (Fig. S4B). NF-
κB-dependent induction of A20, a DUB protecting cells from apoptosis
through inhibition of caspase activation [31,32], thus provides a poten-
tial link between promotion of RelA stability and cell protection from
apoptosis by USP48.
2.5. USP48 preferentially trims long Ub-chains
We then characterized USP48 DUB activity in more detail. While no
catalytic activity of recombinant USP48 could be detected in the DUB-
Glo® Protease Assay, it was detectable for USP48-FL and USP48-CD,
when the Ub C-terminal peptide-based substrate provided with the
kit was replaced by Ub-aminoluciferin (Ub-AML) (Figs. 5A and S5-
1E, F). However, USP48 DUB activity was lower by a factor of about
10 compared to other USPs and 100 compared to UCHL3, a DUB
with high peptidase activity (Figs. 5A and S5-1A–F).While UCHs pro-
fessionally process Ub precursors and remove small adducts from
the C-terminal Gly of Ub, most other DUBs preferentially cleave
isopeptide over peptide bonds [30]. USP48C98A, with the proposed cata-
lytic site Cysmutated to Ala, showedweak catalytic activity in this assay
as well (Figs. 5A and S5-1G).Fig. 4. USP48 stabilizes RelA by deubiquitination. (A, B) RelA-IP from RIPA lysates (A) or total n
added after 15 min) and harvested at the indicated times in the presence of NEM and OPT. (A
or USP48C98A, with the proposed catalytic site Cys mutated to Ala. (C) In vitro DUB assay. RelA
were incubated for 2 h with recombinant GST-USP48-FL in the presence or absence of NEM.
transient knockdown of USP48. (E) HeLa cells were treated or not with CHX directly prior to T
of pro-caspase cleavage (activation) and detection of the 89 kDa fragment of caspase-cleaved
cells treated with TNF and CHX (D) were quantiﬁed and numbers for relative changes indicat
samples, as indicated, from one representative experiment are shown. Tubulin (Cytosol), Nucle
and detected for control of equal protein load. (F) After 1 h pre-treatment or not with pan-casp
times and subsequently to Caspase 3/7-Glo®Assay. Fold changes in caspase activity (mean± s.d
assay. Equal cell numbers were seeded in quadruplicate 1 day after siRNA treatment. Every 2
Viability Assay. (F, G) Knockdown efﬁciency was proved by IB analysis of RIPA cell lysates. (H
the indicated times after transient knockdown of USP48. Relative changes in gene expressio
shown. Data points represent the mean of 2 replicates run in parallel.Ub-chains in FRET-basedUb2-substrates are linked via true isopetide
bonds between the C-terminal carboxylate of the distal Ub and the
ε-amino group of one of the three internal Lys residues (K48, K63 or
K11) of theproximalUb, reﬂecting the as yet best studiedUb-chain link-
age types in cells. Nevertheless, recombinant USP48-FL and USP48-CD
hydrolyzed these substrates with very low efﬁciency compared to
other USPs as well. Yet, all linkage types were hydrolyzed to some
extent, with a preference for K11-linked Ub-chains (Figs. 5B and S5-
2A–G). While USP48-FL cleaved K48- and K63-linked Ub2-substrates
equally well, the latter were hardly cleaved by USP48-CD. UCHL3,
used as negative control, did not hydrolyze Ub2-substrates at all
(Fig. S5-2F), consistent with a previous report [33]. Interestingly, all
USPs tested, except USP48, most efﬁciently hydrolyzed K63-linked
Ub2-substrates. But, while USP15 hardly cleaved K48-linked Ub2, this
was favored over K11-linkedUb2 byUSP5 andUSP7. Togetherwith pub-
lished data [30] these data indicate that although most USPs examined
are promiscuous, hydrolyzing Ub-chains of all linkage types, prefer-
ences for distinct topologies exist.
Low DUB activity of USP48 towards Ub-AML and FRET-based Ub2-
substrates but its ability to counteract UPS-targeting of RelA, led us to
reason if USP48 might preferentially trim long Ub-chains (≥U4), a
property previously observed for Atx3 [34]. K48-linked Ub4 attached
to substrates represents the minimal target signal for proteasomal deg-
radation [35]. Thus, we examined the ability of recombinant USP48 to
hydrolyze Ub4 and Ub3–7-chains of different topology. Very weak disas-
sembly only of K63- and K11-linked Ub4 was detected for USP48-CD,
whereas USP48-FL hydrolyzed Ub4 of all examined linkage types more
efﬁciently (Fig. 5C). Both, USP48-FL and USP15 cleaved M1-linked Ub4
worst. Apart from the latter, USP48-FL hydrolyzed Ub4 of all studied
topologies almost equally well, whereas USP15 hardly hydrolyzed
K48-linked Ub4 alike, consistent with data obtained with FRET-based
Ub2-substrates (Fig. 5B). UCHL3 did not digest Ub4 at all, as reported
previously [36].
Directly comparing the ability of USP48-FL to hydrolyze K48-linked
Ub4 and Ub3–7-chains, we observed it to much more efﬁciently trim
but not completely disassemble UB3–7-chains (Fig. 5D). Accumulation
of Ub1 became most evident in SYPRO-Rubi-stained gels. Ub-chain
disassembly was inhibited by NEM, indicating its dependence on DUB
activity (Fig. 5D). In contrast to USP48-FL, USP48-CD neither hydrolyzed
K48-linked Ub4 nor Ub3–7-chains noticeably (Fig. 5E). Finally, we direct-
ly compared USP48-FLwith USP48-CD and USP48C98A in its efﬁciency to
trim K48-linked Ub3–7-chains (Fig. 5F, G). While Ub-chain trimming,
evidenced by accumulation of Ub2 and Ub1 and a decreasing amount
of long Ub-chains (NUb4), was consistently observed for USP48-FL and
inhibited by NEM, neither USP48C98A (Fig. 5F) nor USP48-CD (Fig. 5G)
hydrolyzed these Ub-chains at all. Similar results were obtained with
overexpressed USP48 variants after their IP from total cell lysates
(Fig. S5-3A). K48-linkedUb4was not hydrolyzed at all by overexpressed
USP48-CD and USP48C98A alike (Fig. S5-3B). These results strongly sug-
gest Ub-chain-trimming by USP48 to essentially depend on sequence
motifs outside the CD and, in contrast to its peptidase activity (Fig. 5A),
on the proposed catalytic site Cys C98.uclear fractions (B) of HeLa cells 15 min pulse-stimulated with TNF (MG132 and/or LMB
, D–H) Transient knockdown of USP48. (B) Overexpression of epitope-tagged USP48-FL
-IPs from total nuclear fractions of HeLa cells 2 h stimulated with TNF as described (A, B)
(D) Subcellular fractionation of HeLa cells stimulated with TNF as described (A, B) after
NF stimulation for indicated times. Apoptosis induction was determined by IB-detection
PARP-1. (D, E) Changes in signal intensity of RelA in the nucleus (C) or RIPA lysates of
ed. RelA signal intensity in non-stimulated control cells was arbitrarily set 1. (A–G) IBs of
olin (N1), HDAC1 (total nucleus, Nt) and Lamin B2 (N2, Nt) were used as marker proteins
ase inhibitor ZVAD-fmk, HeLa cells were subjected to TNF/CHX treatment for the indicated
.) compared to untreated cells are shown (*, p≤ 0.05; **, p≤ 0.01; n=3). (G) Proliferation
4 h cell numbers (mean ± s.d.) were determined with Cell Titer-Glo® Luminescent Cell
) RT-qPCR analysis of NF-κB target gene induction in HeLa cells stimulated with TNF for
n compared to non-stimulated control cells in representative experiments (n = 3) are
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Fig. 6. USP48 catalytic activity is regulated by CK2 (A, B). In vitro CK2 kinase assay with either recombinant GST-USP48-FL or GST-USP48-CD (A) or either epitope-tagged USP48-FL or a
USP48-FL four phosphosite mutant (USP48PS-Mut., as speciﬁed in Fig. 3G), immunoprecipitated from N1 fractions of HeLa cells after overexpression (B), in the presence or absence of CK2
inhibitor VIII. (C) Subcellular location of overexpressed epitope-tagged USP48PS-Mut.. (D–F) Trap-tag-labeling of recombinant GST-USP48-FL (D), GST-USP48-CD (E) or USP15 (F) with HA-
taggedUb-derived suicide probes, as indicated, in thepresence or absence of either NEMor an excess of untagged suicide probe. ReactionswithHA-Ub, lacking a thiol-reactive group,were
included as control. (D) GST-USP48-FLwas additionally subjected to a CK2 kinase reaction prior to and during trap-tag-labeling. (A–F) IBs of samples, as indicated, fromone representative
experiment are shown. Tubulin (cytosol), Nucleolin (N1) and Lamin B2 (N2) served as marker proteins for subcellular fractions (B, C) and were detected for control of fraction purity
(C) and/or equal protein load.
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chains implicated that it might be activated by Ub-chain-binding
through sequence motifs outside the CD. Thus, we subjected it to trap-
tag-labeling reactions with a HA-Ub-derived suicide probe in the pres-
ence or absence of K48- or K63-linked non-hydrolysable (NH) Ub4. In
these probes, Ub, serving as afﬁnity trap for DUBs, is coupled via its
C-term to a thiol-reactive group (vinylsulfone (VS) or vinylmethylester
(VME)), which attacks and covalently modiﬁes the DUB catalytic site
Cys, thus adding a HA-tag to trapped (catalytically active) DUBs.
Labeling of USP48-FL with HA-Ub-VS was enhanced in the presence of
K48- but not K63-linked NH-Ub4 (Fig. 5H), suggesting its selective acti-
vation through association with K48-linked Ub4. Enhanced labeling of
USP48-FL was accompanied by decreased DUB stability, as indicated
by the accumulation of low MW smear (Fig. 5H).Fig. 5. USP48 preferentially hydrolyzes long K48-linked Ub-chains. (A) Hydrolysis of Ub-AML
Results from representative experiments (n = 2–3), each with two replicates run in parallel a
the hydrolysis of TAMRA/QXL570 Ub2-substrates of different Ub-linkage types (100 nM) are c
in the Ub2-substrates. Data points represent the mean of 2–3 independent measurements, each
binantDUBs, as indicated. (C) Kinetics of the hydrolysis of Ub4 of various linkage types by the ind
USP48-CD (E) in the presence or absence of NEMwithin 1.5 h. (F, G) Comparative analysis of K
mutant GST-USP48C98A (G) or GST-USP48-CD (H) in the presence or absence of NEM. (H) HA-U
non-hydrolysable (NH) Ub4. (C–H) IBs or SYPRO-Rubi gel stains of samples, as speciﬁed, from2.6. USP48 catalytic activity is regulated by CK2
In the C-term USP48 possesses high score CK2 phosphorylation sites
(Fig. 3G). Thus we reasoned if CK2-mediated phosphorylation might
affect USP48 catalytic activity. The ability of CK2 to phosphorylate
USP48 at C-terminal sites was conﬁrmed in kinase assayswith recombi-
nant USP48 variants, tagged at the N-term with GST (Fig. 6A). While
USP48-FL was phosphorylated by CK2, this was not the case for GST or
USP48-CD. Phosphorylation of USP48-FL and CK2α subunits themselves
was inhibited by CK2 inhibitor VIII (Fig. 6A). Again, we consistently
observed USP48-FL instability indicated by highly abundant low
MW smear. The latter was more prominently detected with a GST-
speciﬁc antibody than an antibody against the USP48 C-term, sug-
gesting USP48 truncation to proceed from the C-term (Fig. 6A).(250 nM) by various recombinant USPs and UCHL3 in dependence of DUB concentration.
re shown. Also refer to ﬁgure S5-1A–G. (B) Initial catalytic rates of recombinant USPs for
ompared. P1–P4 refers to the position of ﬂuorophore (TAMRA) and quencher (QXL570)
with two replicates. Also refer to ﬁgure S5-2A–G. (C–G) In vitro DUB assays with recom-
icatedDUBs. (D, E) ComparativeUb4/Ub3–7 hydrolysis by eitherGST-USP48-FL (D) orGST-
48-linked Ub3–7 hydrolysis by recombinant GST-USP48-FL and either the catalytic site Cys
b-VS-Labeling of GST-USP48-FL in the presence or absence of NEM and K48- or K63-linked
one representative experiment are shown.
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evidenced in in vitro phosphorylation assayswith recombinant CK2 and
epitope-tagged USP48 variants, which, after overexpression, had beenFig. 7.USP48 becomes phosphorylated at its C-terminal CK2 consensus sites in response to TNF.
ylated by CK2 in response to TNF and interacts with CK2 and CSN. (C) USP48 becomes phosph
USP48 (A, B) or overexpressed epitope-tagged USP48 variants, as indicated, after knockdown o
(LMB added after 15 min) and harvested at the indicated times. (A–C) IBs of samples, as indica
served as marker proteins for subcellular fractions, as indicated, and were detected for controlimmunoprecipitated from N1 fractions of HeLa cells. While CK2
efﬁciently phosphorylated USP48-FL, only marginal phosphorylation
of the USP48-FL CK2 phosphosite mutant (USP48PS-Mut.) with all(A) HA-Ub-VS-labeling of endogenousUSP48 ismodulated by TNF. (B) USP48 is phosphor-
orylated at its C-terminal CK2 consensus sites in response to TNF. (A–C) IP of endogenous
f endogenous USP48 (C) from N1 fractions of HeLa cells 15min pulse-stimulated with TNF
ted, from one representative experiment are shown. Tubulin (cytosol) and Nucleolin (N1)
of equal protein load.
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bined mutation of these sites did not perturb correct subcellular locali-
zation of USP48PS-Mut. (Fig. 6C).
To study the impact of CK2-mediated phosphorylation on USP48
catalytic activity, we performed trap-tag-labeling of recombinant
USP48 in the presence or absence of CK2. Labeling of USP48-FL was
only achieved with HA-Ub-VS. HA-Ub was ineffective, as expected,
and HA-Ub-VS-labeling could be suppressed by preincubation of
USP48 with NEM or a 5-fold excess of non-tagged Ub-VS (Fig. 6D).
When USP48-FL was subjected to an in vitro kinase assay prior to
and during the labeling reaction, labeling was suppressed indicating
that phosphorylation of USP48 in the C-term changes its catalytic
activity (see below). Residual labeling of USP48-FL preincubated
with CK2 could be suppressed by NEM but not a 5-fold excess of
Ub-VS (Fig. 6D). USP48-CD could only be labeled with HA-Ub-VME
(Fig. 6E) and this was inhibited by preincubation with either NEM
or a 5-fold excess of Ub-VME. The different amenability of USP48-
FL and USP48-CD for different thiol-reactive suicide probes indicates
regions outside the CD of USP48 to affect the 3-D structure of the lat-
ter in the full length protein. Overall, labeling efﬁciency of USP48
variants was low compared to USP15, which could be efﬁciently la-
beled with HA-Ub-VS but not HA-Ub-VME (Fig. 6F), likely reﬂecting
USP48's low capability to cleave Ub1-substrates (Ub-AML), as well
as short Ub-chains (Fig. 5A–C).
HA-Ub-VS-labelingwasﬁnally applied again to trace the catalytic ac-
tivity of endogenous USP48 immunoprecipitated from N1 fractions of
HeLa cells. Weak but constitutive labeling of USP48 was lost 1 h and 2
h after TNF stimulation but reappeared after 4 h (Fig. 7A), indicating
modulation of USP48 catalytic activity in response to TNF. The labeled
band of lower MW likely represents C-terminally truncated USP48 gen-
erated during the labeling reaction (Fig. 7A). In support of a functional
role of CK2 in the regulation of USP48 catalytic activity, phosphorylation
of USP48 at CK2 consensus sites as well as co-IP of CK2α and CSN
(CSN3) were observed 2 h after TNF stimulation (Fig. 7B) concurrent
with the loss of USP48 HA-Ub-VS-labeling (Fig. 7A). USP48 phosphory-
lation at its C-terminal CK2 phosphorylation sites in response to TNF
was conﬁrmed after knockdown of endogenous USP48, followed by
reexpression of either siRNA-resistant USP48-FLWT or USP48PS-Mut., the
latter of which did not become modiﬁed (Fig. 7C).
2.7. CK2-mediated phosphorylation of USP48 enhances its Ub-chain
trimming activity
Knowing about the preference of USP48 to trim long K48-linked
Ub-chains, relevant for UPS-dependent turnover of nuclear RelA, we
also analyzed the impact of CK2 and TNF on its ability to disassemble
K48-linked Ub3–7-chains. In contrast to HA-Ub-VS-labeling of USP48,
which was (transiently) lost after TNF stimulation and upon CK2-
mediated phosphorylation (Fig. 7A), phosphorylation of USP48 in
response to 2 h TNF stimulation or with recombinant CK2 in vitro
enhanced its Ub-chain trimming activity (Fig. 8A–C) and this was
inhibited by NEM (Fig. 8A, C) and CK2 inhibitor VIII (Fig. 8B). These
results indicate that CK2-mediated phosphorylation of USP48 at its
C-terminal CK2 consensus sites and its binding to K48-linked Ub-
chains (Fig. 5H), both of which promote USP48 Ub-chain-trimming
activity, trigger a conformational rearrangement in USP48/USP48's CD,
thereby facilitating the trimming of long K48-linked Ub-chains but
simultaneously disabling peptidase activity towards Ub1-substrates
and hydrolysis of short Ub-chains (≤Ub4).
3. Discussion
In the present study we provide ﬁrst direct evidence for USP48 DUB
activity and a profound characterization of catalytic properties and
physiologic function of this as yet ill-characterized DUB predominantly
localized in the nucleus. We demonstrate that (I) USP48 preferentiallytrims long (K48-linked) Ub-chains, an as yet unique property within
the USP family, (II) CK2 phosphorylates USP48 at C-terminal CK2 con-
sensus sites, thereby enhancing its Ub-chain-trimming activity (III)
USP48 and CSN directly interact in the nucleus, where they cooperate
in the control of nuclear accumulation and ECSSOCS1-dependent RelA
ubiquitination, thus contributing to timely proteasomal degradation of
RelA.
3.1. USP48 has unique catalytic properties within the USP family
We demonstrate for the ﬁrst time that puriﬁed recombinant USP48,
a DUB of hitherto largely unknown physiologic function, is catalytically
active and has unique catalytic properties within the USP family. Most
remarkable among these is the high efﬁciency of USP48-FL but not
USP48-CD or the catalytic site Cys mutant USP48C98A to trim but
not completely disassemble long K48-linked unanchored Ub-chains
(Figs. 5D–G and S5-3A, B). This property contrasts with the low pepti-
dase activity towards Ub-AML (Figs. 5A and S5-1A–G) and the low
isopeptidase activity towards FRET-based Ub2-substrates (Figs. 5B and
S5-2A–G) and unanchored Ub4 (Fig. 5C). The ability to efﬁciently trim
long (NUb4), yet to largely spare short (K48-linked) Ub-chains (≤Ub4)
clearly distinguishes USP48 from USP7, recently described as another
DUB antagonizing ubiquitination of nuclear/promoter-bound RelA
[37]. In contrast to USP48, USP7 efﬁciently cleaves Ub-AML and FRET-
based Ub2-substrates, the latter however to some extend depending
on the Ub linkage type. Furthermore, USP7 poorly disassembles long
K48-linked Ub-chains (≥Ub4) attached to model substrates in vitro
but instead efﬁciently removes short Ub-chains (bUb4) and mono-Ub
from substrates [38].
3.2. Catalytic properties of USP48 partially resemble those of Atx3 and Otu1
Catalytic properties similar to USP48have, as yet, only been reported
for theMJD family DUB Atx3 [34] and the OTU family DUB Otu1 [39,40].
Atx3 consists of an N-terminal catalytic Josephin domain and twoUb in-
teraction motifs (UIMs) in the C-terminal half of the protein, followed
by a polyglutamine domain and, depending on the splice variant, a
third UIM [41]. In Atx3, like USP48 poised to trim long K48-linked
Ub-chains but to spare short Ub-chains [34], the UIMs are reportedly re-
quired to efﬁciently bind poly-Ub-chains and to protect short Ub-chains
(≤Ub4–6) from disassembly, as well as a ubiquitinated model substrate
from capture and degradation by the proteasome. Notably, model sub-
strate stabilization by Atx3 was shown to be independent from its
catalytic activity, which however trimmed substrate-attached poly-
Ub-chains down to Ub4-6 [34]. Similarly, overexpressed USP48C98A,
lacking Ub-chain-trimming activity (Figs. 5F and S5-3A), supported
TNF-induced RelA nuclear accumulation as effectively as USP48-FL
(Fig. 4B, 30 min TNF), likely through the occupation of short Ub-
chains (up to Ub4) attached to RelA, thereby protecting it from capture
by the proteasome. In contrast to USP48-FL however, due to its inability
to trim long Ub-chains, it did not prevent a decrease of nuclear RelA
from1 h after TNF stimulation due to polyubiquitination andmovement
into the HMW fraction. Yet, unlike Atx3, USP48 does not possess any
known Ub-binding domain except the USP domain. But it is tempting
to speculate that the three DUSP domains in the C-terminal half of
USP48 are unrecognized Ub-binding domains. USP48 is the only
USP possessing three DUSP domains, some other USPs possessing two
(USP20 and USP33) or at least one of them (USP11, USP15 and USP32)
[30].
While Otu1 preferences for Ub-chain length and linkage type
resemble those of USP48 and Atx3 [39,40], Otu1 only consists of an
N-terminal Ub regulatory X (UBX)-type UBL, recruiting it to the
AAA ATPase Cdc48/p97/VCP [39,40], the catalytic OTU domain and a
C-terminal zinc ﬁnger [30]. Of interest in relation to USP48, bidentate
substrate-binding based on two different Cys residues, (I) the catalytic
site Cys, susceptible for modiﬁcation/inactivation by Ub-aldehyde but
Fig. 8. CK2-mediated phosphorylation promotes USP48 Ub-chain trimming activity. (A–C) DUB assays with USP48 immunoprecipitated from N1 fractions of non-stimulated
HeLa cells (A,B) or HeLa cells stimulated with TNF for the indicated times (C) and K48-linked Ub3–7 chains as substrate in the presence or absence of either NEM (A, C) or
CK2 inhibitor VIII. IBs of samples, as indicated, from one representative experiment are shown. Nucleolin (N1) was used as marker protein and detected as control for equal protein
load. (A, B) Prior to and during the DUB assay USP48 was subjected to in vitro phosphorylation by recombinant CK2. (D) Model for the impact of CSN-associated USP48 on RelA nuclear
turnover. (1) USP48 stabilizes RelA upon its cytokine-induced nuclear entry, facilitating RelA nuclear accumulation. (2) USP48 Ub-chain-trimming activity is (transiently) enhanced upon
its phosphorylation by CK2. (3) USP48 is inactivated by dephosphorylation and/or release from RelA and the CSN. (4) In absence of USP48, RelA becomes efﬁciently polyubiquitinated by
ECSSOCS1 and subsequently degraded via the UPS in PML nuclear bodies.
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for HA-Ub-VS labeling, but only when the catalytic site Cys is occupied
with Ub-aldehyde, was described for Otu1 [42]. Although engagement
of both Cys residues in catalysis was not reported, this feature of Otu1
somehow reminds of USP48: the latter being amenable for HA-Ub-VS-labeling (and possessing low peptidase activity independent of catalytic
site Cys C98) in the absence of CK2-mediated phosphorylation but be-
coming labeling resistant (peptidase inactive) upon phosphorylation
and the presence of long Ub-chains (NUb4). Both enhance USP48's
isopeptidase/Ub-chain trimming activity, which essentially depends
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isopeptidase/Ub-chain-trimming activity on alternate catalytic site Cys
residues, an issue outside the focus of our study, requires further explo-
ration through e.g. structural biology.
3.3. CSN and USP48 cooperatively control the nuclear turnover of RelA
In response to TNF stimulation, ubiquitination and UPS-dependent
degradation of activated RelA proceed in the insoluble nuclear fraction
enriched for PML and subunits of the 20S proteasome (Figs. 1A–C and
S1A). This fraction likely corresponds to PML nuclear bodies [43],
dynamic subnuclear compartments representing centers for proteolytic
degradation upon response to various stresses [44,45]. Concordant with
previous reports [4,5] we identiﬁed ECSSOCS1 as Ub-E3 for RelA and
observed ECSSOCS1 subunits to accumulate in the nucleus upon cell
treatmentwith TNF and LMB (Fig. 2D, E). CRL-dependent ubiquitination
and TNF-induced association of RelA with the CSN in the nucleus
(Figs. 1A and 3A, C) suggested the CSN, a master regulator of CRLs, to
be decisively involved in the control of RelA nuclear turnover. Congru-
ently, enhanced RelA-Ub accumulation was observed in CSN-depleted
cells stimulated with TNF in the presence of MG132 (Fig. 2A), which in-
dicated the CSN to act as an antagonist of RelA ubiquitination through
either CRL inactivation (deneddylation) or RelA deubiquitination by
an associated DUB.
Through a siRNA screenwe identiﬁed USP48 asmost promising DUB
candidate regulating the nuclear turnover of RelA. USP48 and the CSN
constitutively interact in the nucleus. Upon TNF-induced nuclear entry
they immediately associate with RelA to collaboratively promote its
nuclear accumulation and antagonize its polyubiquitination and
degradation via the UPS. Our data are thus consistent with the CSN
stabilizing RelA through an associated DUB. The association of USP48
with RelA is likely strengthened upon RelA ubiquitination. Through
binding-mediated occlusion of short Ub-chains (up to Ub4) attached
to RelA, USP48might prevent RelA-Ub capture by the UPS, thus stabiliz-
ing RelA independent of catalytic activity (Fig. 4B). Ub-chain elongation
however is antagonized by USP48 Ub-chain trimming activity, which,
likely through conformational rearrangement, is promoted upon USP48
Ub-chain-binding. CK2-mediated phosphorylation of USP48 at C-
terminal CK2 consensus sites, in vitro and in response to TNF, enhances
its Ub-chain-trimming activity (Fig. 8A–C). In response to TNF however,
phosphorylation of USP48 is transient (Fig. 8C). Thus, dephosphorylation
of USP48 and/or its release from RelA and the CSN through an unknown
mechanism ﬁnally allow efﬁcient polyubiquitination of RelA by ECSSOCS1,
mediating its proteasomal degradation (Fig. 8D). Interestingly, associa-
tion of CK2 with the CSN and CK2-mediated phosphorylation of its sub-
units CSN2 and CSN7 have been observed [46], implying potential
reciprocal regulation of CK2 and CSN activities, which might impact on
timing of USP48 phosphorylation, Ub-chain trimming activity and asso-
ciation with the CSN. Although CK2, a highly conserved protein kinase
with brought substrate speciﬁcity and pronounced pro-proliferative
and anti-apoptotic activities, is widely viewed as constitutively active
messenger-independent enzyme [47], a multitude of mechanisms
potentially contributing to keep its activity in check in vivo, including
regulated localization/turnover and association with other proteins,
have been suggested [48].
In summary, we hypothesize one profession of USP48 to be protec-
tion of either the entire nuclear or the nucleoplasmic pool of RelA, as op-
posed to the chromatin-bound fraction being just yet transcriptionally
engaged [49], from premature degradation via the UPS, thus extending
the timespan of RelA's availability for transcriptional engagement. This
might be of paramount importance, since induction of individual in-
ﬂammatory genes is subject to divergent temporal control on multiple
levels, but in each case essentially requires timely and dynamic supply
of NF-κB (RelA) for transcription to proceed [50,51]. Short Ub-chains
attached to RelA might either persist or be removed by other DUBs,
e.g. USP7 [37], upon transcriptional engagement and “DUB exchange”.The presence of short Ub-chains on RelA, shielded from or just below
the threshold for capture by the proteasome, could enhance the prompt-
ness of RelA degradation at appropriate times.
4. Materials and methods
4.1. Eukaryotic expression constructs
A true ORF clone encoding full length usp48 attributed with a
C-terminal Myc-Flag-tag, integrated into the pCMV6Entry vector,
was purchased from Origene. The expression construct for RelA was
generated by cloning the PCR-ampliﬁed cDNA encoding for human
relA into the pcDNA™3.1 expression vector (Invitrogen). In addition,
a sequence encoding the His6-tag and the T7-tag was included in the
5′-end PCR primers. Constructs for USP48-FL and the USP48 CD (aa
1–450), attributed with an N-terminal Flag-tag were generated by
integrating the PCR-ampliﬁed ORF encoding for human FL usp48 or
a shorter fragment encoding for the usp48 CD into the pENTR™-SD/
D-TOPO® vector (Invitrogen). Additionally, a sequence encoding
the Flag-tag was attached to the 5′-end PCR primers. Exploiting the
Gateway® system (Invitrogen), the cDNA ORFs integrated in the
pENTR™-SD vector were then subcloned into the pCDNA™3.2/V5-DEST
expression vector (Invitrogen). USP48C98A with the catalytic site Cys
mutated to Ala, and a USP48-FL CK2 phosphosite mutant (USP48PS-Mut.)
with serines 886–888 and Thr 890 allmutated to alanine, both possessing
a C-terminal Myc-Flag-tag, were generated by site-directed mutagenesis
(GeneArt® Site-Directed Mutagenesis Plus Kit, Life Technologies). All
constructs generated during this study were veriﬁed by sequencing
(GATC Biotech).
4.2. Recombinant proteins and human puriﬁed CSN
Recombinant proteins were obtained from following sources: CK2
(New England Biolabs), GST (GeneScript), Flag-Myc-RelA (OriGene),
human COP9 signalosome (hCSN) puriﬁed from erythrocytes, His6-
UCHL3 and His6-USP15 (ENZO Life Sciences), His6-USP7-FL and USP5/
isopeptidase T-FL (Boston Biochem) and GST-USP48-FL (Abnova). GST-
USP48-CD (USP48 catalytic domain, aa 1–450) and GST-USP48C98A were
custom-cloned and synthesized using a wheat germ-based in vitro trans-
lation system followed by afﬁnity puriﬁcation (Abnova). Constructs were
veriﬁed by sequencing (Abnova).
4.3. Cell culture, cell treatments and transfection
HeLa (CCL2) cells (ATCC) and HEK293 cells (ATTC) were cultured in
RPMI 1640 medium (PAA), supplemented with FCS (10%, Biochrom),
HEPES (20 mM) and Penicillin/Streptomycin (100 U/ml, PAA). At least
24 h prior to transfection or stimulation with TNF (10 ng/ml, R&D
Systems) or IL-1β (15 ng/ml, Peprotech) cells were seeded on Petri-
dishes. 4 h–16 h prior to treatments theywere transferred intomedium
free of serum and antibiotics (OptiMEM, Life Technologies). Transient
transfections for protein overexpression were carried out in OptiMEM
medium using 3–5 μg cDNA per 100 mm diameter dish and the
Effectene transfection kit (Qiagen). 6 h post-transfection fresh medium
with FCS was added and cell culture continued for 20 h. Transient
knockdown of proteins of interest by siRNAwas performed as described
previously [8] using siRNA duplexes at a ﬁnal concentration of 50–
75 nM and the SiLentFect Lipid Reagent (Bio-RAD). A non-targeting
siRNA (Eurogentec or Life Technologies, depending on the source of the
targeting siRNA) was used as control. Cells were harvested the 3rd
day after siRNA transfection or at times indicated in the ﬁgures. Most
siRNA duplexes were custom designed and purchased from Eurogentec.
A predesigned Silencer® Select siRNA targetingUSP48was bought from
Life Technologies. siRNA sequences and order details are listed separately
(Table S1). CHX (Sigma), MG132 (Tocris), LMB (Calbiochem) and ZVAD-
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25 μM, 10 ng/ml and 10 μM respectively.
4.4. Cell proliferation assay
To analyze the impact of siRNA treatment on cell proliferation/via-
bility, the Cell Titer-Glo® Luminescent Cell Viability Assay (Promega)
was used according to the manufacturer's instructions. In brief: One
day after targeting/non-targeting siRNA transfection, cells were har-
vested by trypsination and equal cell numbers (10,000/well) seeded in
quadruplicate on white, ﬂat, clear bottom 96 well plates in a volume
of 100 μl. At least 4 h prior to analysis at day 1 to 4 (24–96 h) after cell
seeding, the culture medium was replaced by 40 μl fresh medium/
well. Assays were then performed according to instructions and read
on a Spectramax M5 plate reader (Molecular Devices) equilibrated to
25 °C and set to detect luminescence at all wavelength with an integra-
tion time of 500 msec and a settling time of 100 msec in an endpoint
measurement. Obtained results were blank-subtracted against cell-
free culture medium. Applying the assay to a 1:2 serial dilution of
HeLa cells, the assay was calibrated to determine cell numbers. A linear
relationship between cell number and luminescence signal was
obtained for up to 90,000 cells per well. In parallel, viability of siRNA-
transfected cells, seeded on 60mmdiameter petri dishes and harvested
by trypsination at days 1 to 4 after seeding, was determined using
Countess Cell Counter (Life Technologies). At day 3 post transfection
RIPA lysates (see below)were prepared from harvested cells to conﬁrm
knockdown success by immunoblot (IB).
4.5. Apoptosis assay
Induction of apoptosis by cell treatment with TNF and CHX was
determined by use of the Caspase-Glo® 3/7 Assay (Promega) according
to the manufacturer's instructions. In brief: One day after targeting/
non-targeting siRNA transfection, cells were harvested by trypsination
and 10,000 cells/well seeded in triplicate per experimental sample on
a white, ﬂat, clear bottom 96 well plate in a volume of 100 μl complete
cell culture medium. At least 12 h prior to cell treatment with TNF and
CHX after pre-incubation or not for 1 h with pan-caspase inhibitor
ZVAD-fmk, as indicated in the ﬁgure, cell culture mediumwas replaced
by 40 μl OptiMEM medium supplemented with 0,1% FCS per well. All
reactions were stopped simultaneously through addition of an equal
volume of Glo-Reagent pre-adapted to 25 °C and reactions subsequently
incubated for 10 min with continuous shaking on a plate shaker at 25 °C.
Luminescence generated was afterwards immediately read on a
Spectramax M5 plate reader, using the settings described in the upper
paragraph. Results were blank-subtracted against cell-free medium sup-
plemented with vehicle (DMSO). Knockdown success was conﬁrmed by
IB analysis of RIPA lysates generated from cells, which had been seeded
in parallel on 60 mm diameter petri dishes. Statistical signiﬁcance of
data obtained from 3 independent experiments was analyzed applying
paired Student's T-test.
4.6. Preparation of whole cell extracts
Cells grown on Petri-dishes (10 cm diameter) were washed twice
in ice-cold PBS and then scraped into 450 μl RIPA buffer (50 mM Tris
(pH 7.5), 5 mM EDTA, 150 mM NaCl, 10 mM K2HPO4, 10% Glycerol, 1%
Triton X-100 and 0.05% SDS), supplemented with 20 mM NaF, 1 mM
Na3VO4, 1 mM Na2MoO4, 20 mM 2-phospho-glycerate (2-PG), 1 mM
AEBSF and 1× EDTA-free protease inhibitor cocktail (PI/Roche). Lysates
were incubated for 10 min on ice and cell lysis completed by passing
them 5 times through a 27-gauge injection needle. Afterwards, lysates
were cleared by centrifugation (13,000 ∗g, 4 °C, 10 min). The following
compounds were added to the RIPA buffer when required, as indicated
in the ﬁgure legends: N-ethyl-maleimide (NEM, 7.5 mM, Fluka), 1,10-
ortho-phenanthroline (OPT, 5 mM, Sigma) and MG132 (25 μM). Inexperiments, where preservation of USP48 catalytic activity was re-
quired, RIPA buffer was replaced by Igepal lysis buffer (25 mM HEPES
(pH 7.5), 150 mM NaCl, 5 mM EDTA, 10% Glycerol and 0.5% Igepal
(Sigma)), only supplemented with 1 mM DTT, 1 mM AEBSF
(AppliChem) and 25 μM MG132. LMB was only used in experiments
with cytokine stimulation and cell harvest by subcellular fractionation
(see below).
4.7. Subcellular fractionation
Cells grown on Petri-dishes (10 cm diameter) were washed twice
with ice-cold buffer A (10 mM Tris (pH 7.9), 10 mM KCl, 1.5 mM
MgCl2, 10 mM K2HPO4, and 10% Glycerol) devoid of inhibitors and
subsequently scraped into 450 μl pre-chilled buffer A supplemented
with DTT (0.5 mM), AEBSF (1 mM), PI/Roche (1×), 2-PG (20 mM), NaF
(20 mM), Na3VO4 (1 mM) and Na2MoO4 (1 mM). Cell suspensions
were incubated for 10min on ice to allow the cells to swell. Afterwards,
1 μl of 12.5% Igepal was added per 100 μl cell suspension to initiate cell
lysis, which was allowed to proceed for 5 min on ice with incidental
shaking. Nuclei were separated from cytosolic supernatants by centrifu-
gation (2000 ∗g, 4 °C, 10min) and cytosolic fractions afterwards cleared
(13,000 ∗g, 4 °C, 10min). Nuclear pellets (P1)werewashed once in buff-
er A (300 μl) and then resuspended in 50 μl buffer C (20 mM Tris (pH
7.9), 420 mM NaCl, 1.5 mMMgCl2, 0.2 mM EDTA, 10 mM K2HPO4, and
10%Glycerol), supplemented as described for buffer A, to extract soluble
nuclear proteins (N1). After incubating the samples for 30 min on ice
with incidental shaking, N1 fractions were harvested by centrifugation
(13,000 ∗g, 4 °C, 10 min). Pellets (P2) were resuspended in 50 μl buffer
E (20mMTris (pH 8.0), 150mMNaCl, 1% (w/v) SDS, 1% (v/v) Igepal and
10 mM iodacetamide), supplemented as described for buffer A, with
DTT omitted. Directly before use, buffer E was additionally
supplemented with Benzonase® Nuclease (25 U/ml, Novagen). After
incubating the samples for 30 min on ice with incidental shaking to
extract insoluble nuclear proteins (N2) and to digest chromatin, N2
fractions (supernatants) were harvested by centrifugation (13,000 ∗g,
4 °C, 10 min) and pellets (P3) discarded. Total nuclear extracts (Nts)
containing both, soluble and insoluble nuclear proteins were prepared
by directly extracting buffer A-washed nuclear pellets (P1) in buffer E
with supplements. The following compounds were added where re-
quired to the fractionation buffers, as indicated in the ﬁgure legends:
NEM (7.5 mM), OPT (5 mM), MG132 (25 μM) and LMB (10 ng/ml,
only buffer A). In experiments where USP48 catalytic activity needed
to be preserved, HEPES- instead of Tris-based buffers without any sup-
plements, except DTT (0.5 mM), AEBSF (1 mM) and MG132 (25 μM)
were used. Protein concentrations were determined by use of Bio-RAD
Protein Assay (Bio-RAD) according to the manufacturer's instructions.
4.8. Immunoprecipitation and Western Blot
For IPs from whole cell extracts (WCEs) or cytosolic fractions equal
amounts of protein (0.5–1 mg in a volume of 400 μl) were diluted
(1:2) with IP buffer (20 mM Tris or HEPES (pH 7.4), 150 mM NaCl,
2 mM EDTA and 0.05% Triton X100) supplemented with AEBSF
(1 mM), PI/Roche (1×), 2-PG (20 mM), NAF (20 mM), Na3VO4 (1 mM)
andNa2MoO4 (1mM). 1 μg protein-speciﬁc antibody (or 2.5 μl CSN1 an-
tibody, ENZO Life Sciences) was added per reaction and samples incubat-
ed 4 h to over-night on a permanent rotator (7 rpm) at 4 °C. Afterwards,
reactions were loaded on protein G sepharose beads (GE Healthcare,
25 μg per reaction), which had been previously four times washed in
800 μl IP buffer supplemented with PI/Roche (1×). Immune complex
immobilization was allowed to proceed for 2 h at 4 °C. After centrifuga-
tion (500 ∗g, 2 min, 4 °C), supernatants were discarded and immune
complexes 4–6 timeswashed in 800 μl IP buffer containing all inhibitors
(500 ∗g, 2 min, 4 °C). After complete removal of the supernatants, beads
were suspended in 40 μl 2× Laemmli sample buffer and β-ME (2.5 μl)
added. Afterwards, samples were incubated with continuous shaking
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complexes were recovered and analyzed by SDS PAGE and IB. For anal-
ysis of protein ubiquitination, the IP buffer was additionally supple-
mented with NEM (7.5 mM), OPT (5 mM) and MG132 (25 μM). In
case of USP48-IP from WCEs, intended for subsequent use in DUB
assays, the IP buffer, including supplements, was replaced by Igepal
lysis buffer (refer to “preparation of whole cell extracts”). In case of
T7(RelA)-IPs, protein G sepharose beads were pre-loaded with T7-
antibody (1 μl per reaction). For Flag(USP48)-IPs Flag-agarose beads
(Sigma) were used. In both cases, diluted samples were directly applied
to washed antibody-loaded beads (25 μg per reaction), rotated 4 h to
over-night and captured immune complexes handled as described
above. Nuclear fractions were diluted with salt- (N1) or detergent-free
buffer (N2, Nt) prior to IP to regenerate salt (N1) or detergent concen-
trations (N2, Nt) compatible with immune complex formation. Equal
amounts of protein (200–500 μg) were then used per IP reaction and
IPs performed as described. To suppress unspeciﬁc protein binding to
beads, captured immune complexes were washed twice in IP buffer
with increased salt (up to 300 mM NaCl) or Igepal concentration (up
to 0.5% v/v), where required, before the standard washing procedure
was performed. Prior to application of IPs to trap-tag-labeling reactions
or DUB assays, theywere additionallywashed twice inDUBassay buffer,
supplemented with protease inhibitors (refer to later paragraphs).
Samples (10 μg protein per lane, or equal aliquots of DUB assays or
IPs) were separated on SDS-PAGE gels and transferred to PVDF mem-
branes (Millipore). SeeBlue® Plus2 pre-stained standard (Life Technolo-
gies) was additionally run as MW marker on each gel. IB detections
were performed using antibodies, as indicated in the ﬁgures and listed
separately (Tables S2 and S3), and either Amersham ECL™Western
Blotting Detection Reagents (GE Healthcare) or the SuperSignal® West
Dura Extended Duration Substrate Kit (Thermo Scientiﬁc). Images of
IBs were obtained by ﬁlm development, followed by ﬁlm scanning, or
captured by use of a CCD camera-based gel/blot imaging system
(Chemostar Professional, INTAS). Densitometric analysis of scans or raw
images was performed with Image Studio Lite 3.1 (Licor). For visual pre-
sentation images were processed with Photoshop 11.0.2.
4.9. Pulldown assays with recombinant proteins or puriﬁed CSN
Equal molar amounts [μg] of recombinant proteins or puriﬁed hCSN,
as indicated in the ﬁgures (Figs. 3D–F and S3C, D) were coincubated in
HEPES-based IP buffer supplemented with PI/Roche (1×), AEBSF
(1 mM), 2-PG (20 mM) and Prionex (0.1%, Polysciences) for 2 h at 4 °C
with continuous shaking in aﬁnal reaction volumeof 100 μl. Afterwards,
reactions were loaded on either anti-Flag(M2) agarose or protein G se-
pharose beads (40 μl 50% beads per reaction) preloaded with anti-GST
antibody (1 μg per reaction), as indicated in the ﬁgures. Prior to their
use for IP, free protein binding sites of antibody-loaded beads were
blocked by rotating the beads in IP buffer additionally supplemented
with 1.5% Prionex (2 h, 4 °C, 7 rpm). Afterwards, beads were washed
and then resuspended in 100 μl IP-Puffer containing 0.49% Prionex. Pro-
tein reactionswere then added to the beads, resulting in a ﬁnal reaction
volume of 200 μl and a ﬁnal Prionex concentration of 0.25%. IP reactions
were rotated for 2 h at 4 °C and 7 rpm. After four washes in IP buffer
(2 min, 4 °C, 500 ∗g), supernatants were completely removed and
discarded. Captured immune complexes were eluted by shaking the
beads in 30 μl 2× Laemmli buffer supplementedwith 2.5 μl β-ME per re-
action (5 min, 95 °C). Eluted immune complexes were harvested by
centrifugation and equal aliquots of samples analyzed by SDS-PAGE
and IB, as indicated in the ﬁgures.
4.10. Trap-tag-labeling of DUBs
Trap-tag-labeling of recombinant DUBs or DUBs immunoprecipitated
from cells was adapted from literature [52]. Recombinant DUBs
(0.5 μM)were preincubated for 5 min at 30 °Cwith continuous shakingin DUB assay buffer (50 mM HEPES (pH 7.5) with 100 mM NaCl), sup-
plemented with DTT (1 mM) and AEBSF (1 mM) in the presence or ab-
sence of Ub-VS (15 μM), Ub-VME (15 μM), both obtained from Boston
Biochem, NEM (10 mM), ATP (200 μM), MgCl2 (2 mM) and/or CK2
(0.5 U/15 μl reaction, New England Biolabs), as indicated in the ﬁgures.
After 5 min, HA-Ub, HA-Ub-VS or HA-Ub-VME (3 μM, ENZO Life
Sciences) were added, as indicated in the ﬁgures, and labeling reactions
allowed to proceed for 1 h at 30 °Cwith continuous shaking in a reaction
volume of 15 μl. Afterwards, 5 μl 4× Laemmli sample buffer and 1.5 μl
β-ME were added per reaction and samples boiled (5 min, 95 °C).
Equal aliquots of all reactions were analyzed by SDS-PAGE and IB, by
the use of the indicated antibodies. For labeling of DUBs (endogenous
or ectopically expressed) immunoprecipitated from cell extracts,
MG132 (25 μM) was additionally added to the labeling reactions.
4.11. In vitro DUB assay
For kinetic Ub4 DUB assays, recombinant DUBs (0.5 μM)were prein-
cubated for 5 min at 30 °C with continuous shaking in DUB assay buffer
supplemented with DTT (1 mM) and AEBSF (1 mM). Ub4 of different
linkage types was then added (3 μg) and incubation of all reactions
(30 μl) continued for up to 60 min at 30 °C with continuous shaking.
At various times aliquots (6.5 μl) were taken from each reaction, com-
bined with 8.5 μl 2× Laemmli sample buffer and 1.5 μl β-ME, boiled
(5 min, 95 °C), centrifuged and stored at −80 °C. Equal aliquots of all
samples were separated by SDS-PAGE and analyzed by IB.
Endpoint DUB assays using either recombinant USP48 variants
(0.5 μM) or USP48 variants immunoprecipitated from cell extracts as
DUB source and either ubiquitinated immunoprecipitated RelA or
Ub-chains of different linkage types as DUB substrate (Ub4 (1.5 μg) or
Ub3–7 (1.9 μg)), were performed in the presence or absence of NEM
(10 mM) in a ﬁnal reaction volume of 15 μl. In case of Ub3–7-chains an
average MW of 40 kDa was assumed to calculate molarities. Reactions
were stopped after 1.5–2 h incubation by addition of 5 μl 4× Laemmli
sample buffer and 2 μl β-ME and then boiled (5min, 95 °C). Afterwards,
samples were handled as described above. In some cases SDS-PAGE-
separated samples were additionally analyzed by SYPRO Rubi gel stain
(Bio-RAD), which was performed according to the manufacturer's in-
structions. Images of SYPRO-Rubi-stained gels were captured using the
Chemostar Professional imaging system equipped with a 312 nm UV
transilluminator for excitation and a SYPRO-Rubi emission ﬁlter (INTAS).
4.12. Luminescence assay for DUB activity
Luminescence assays for DUB activity were performed using the
DUB-Glo™ Protease Assay Kit (Promega) as described [53]. The
luminogenic substrate (Z-RLRGG-aminoluciferin) provided with the
kit was replaced by Ub-AML (Boston Biochem). Serial (1:2) dilutions of
DUBs prepared in DUB assay buffer, supplemented with DTT (2 mM),
AEBSF (1 mM) and Prionex (0.1%), were placed into wells of white
opaque 96 well half area plates (Greiner, 30 μl reaction volume). Plates
were then prewarmed (5 min, 30 °C) with continuous shaking. After-
wards, 30 μl DUB-Glo™ reagent supplemented with Ub-AML (0.5 μM)
was added to each reaction, generating the ﬁnal concentration of
Ub-AML (250 nM) and theﬁnal concentrations of theDUBs, as indicated
in the ﬁgures (Figs. 5A and S5-1A–G). Reactions were immediately
monitored for 45 min on a Spectramax M5 plate reader with readings
taken every 20 s to 1 min and the reader set to detect luminescence at
all wavelengths with an integration time of 500 msec. On each plate
reactions were performed in duplicate. After data export to Excel,
plots of kinetic measurements were generated with each data point
representing the mean of two replicates. Relative luminescence (RLU)
values peaked after about 3 min, depending on DUB type and DUB con-
centration. From each serial DUB dilution the RLU value at peak level
was determined. For eachDUB analyzed, these valueswere then plotted
against DUB concentration and graphs ﬁtted by linear regression.
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DUB assays with FRET-based Ub2-substrates were adapted from
literature [54]. Dilutions of recombinant DUBs (15 μl) in DUB assay
buffer, supplemented with DTT (1 mM) and AEBSF (1 mM), were
placed in duplicate into wells of a black opaque 96 well half area
plate (Greiner) and the plate then prewarmed (5 min, 30 °C) with
continuous shaking. Afterwards, an equal volume of FRET-TAMRA/
QXL570 Ub2-substrates (Boston Biochem) of different linkage type
(K48, K63 or K11) and labeling position for the ﬂuorescent dye
TAMRA and the quencher molecule QXL570 (P1-P4, Figs. 5B and
S5-2A–F), prepared in DUB assay buffer (200 nM) as well, was added
to each well, resulting in the ﬁnal concentration of the Ub2-substrates
(100 nM) and theﬁnal concentrations of theDUBs, as indicated in theﬁg-
ures, in a reactionﬁnal volumeof 30 μl. Kinetics of substrate conversion in
each well was then immediately monitored on a Spectramax M5 plate
reader set to detect ﬂuorescence at ex544 nm and em572 nm for
60 min. A reading was taken every 20 s without time delay. Data were
exported to Excel and plots for time-dependent substrate conversion in
each reaction generated. A calibration curve for the ﬂuorescence increase
resulting from TAMRA-Ub release upon Ub2-cleavage by DUBs was
established by the use of 5-TAMRA-Lys(Ub)-Gly-OH (Boston Biochem)
and exploited to convert measured relative ﬂuorescence units (RFU
values) into the amount of TAMRA-Ub generated [nM]. Finally, initial
catalytic rates [s−1] at the ﬁxed substrate concentration (100 nM) were
calculated for each DUB analyzed by division of the determined initial
cleavage velocity by enzyme concentration.
4.14. Polymerase chain reaction
RNA was extracted from 5 ∗ 106–1 ∗ 107 cultured cells using the
InnuPREP RNA Mini Kit (Analytik Jena). Per reaction 1.5 μg RNA
were reverse transcribed using MMLV reverse transcriptase and the
First Strand cDNA Synthesis Kit (Thermo Scientiﬁc). RT-qPCRs were
run on a StepOnePlus™ real time qPCR platform (Applied Biosystems)
by the use of 1 μl cDNA per reaction, target gene-speciﬁc primer pairs
and the SensiMix™ SYBR Kit (Bioline). Per 96 well PCR plate samples
were analyzed in duplicate for at least one target gene of interest and
gapdh, used as reference gene for normalization. In addition, relative
cDNA calibration curves for both, target gene(s) of interest and
gapdh were run on each plate. Relative quantities of the target
gene(s) of interest and gapdh were then determined by use of their
respective calibration curves and the results obtained for the
gene(s) of interest normalized against those obtained for gapdh.
Afterwards, relative changes in target gene expression, e.g. during
a time course of TNF-stimulation, were determined by dividing
the result obtained for each sample by the result obtained for
the reference sample (usually the sample generated from non-
transfected and non-stimulated cells). RT-qPCR speciﬁcity was
controlled by no-template and no-RT samples, as well as by melting
curve analysis. Sequences of human gene-speciﬁc primer pairs used
in the study are provided separately (Table S4).
4.15. CK2 kinase assay
Recombinant CK2 (0.5 U/reaction) was preincubated for 10 min at
30 °C with continuous shaking in DUB assay buffer supplemented
with DTT (5 mM), AEBSF (1 mM), ATP (200 μM) and MgCl2 (2 mM) in
the presence or absence of CK2 inhibitor VIII (1 μM). Afterwards, recom-
binant GST or GST-tagged USP48 variants (GST-USP48-FL or GST-
USP48-CD) were added and kinase reactions (15 μl ﬁnal) performed
for 1 h at 30 °C with continuous shaking. After 1 h, reactions were put
on ice, supplemented with 5 μl 4× Laemmli sample buffer and 2 μl
β-ME and then boiled (5 min, 95 °C). Equal aliquots of all samples
were separated by SDS-PAGE and analyzed by IB. Kinase reactions
with endogenous USP48 or epitope-tagged USP48 variants as thesubstrate, after their overexpression in HeLa cells and anti-Flag-IP
from N1 nuclear fractions, were performed as follows: recombinant
CK2, pre-incubated for 10 min in a reaction volume of 15 μl in the pres-
ence of DTT (5 mM), AEBSF (1 mM), MG132 (25 μM), ATP (200 μM),
MgCl2 (10mM) and CK2 inhibitor VIII (1 μM), as indicated in the ﬁgures
(Figs. 6B and 8A, B),was added towashed IPs and samples then incubat-
ed for 1 h at 30 °C and further handled as described above.4.16. RNAi DUB screen
To identify candidate DUBs potentially involved in the regulation of
nuclear NF-κB, a Silencer® select/Silencer siRNA DUB screen was
established/valuated in cooperation with and then performed by Cenix
BioScience GmBH (Dresden, Germany). In brief, each of the 100 target
genes, encompassing all assigned human DUBs, as well as positive and
negative controls, was screened by 3 individual siRNAs (Life Technolo-
gies) in experimental triplicates. As a readout, nuclear translocation of
RelA 30 and 60 min post TNF (10 ng/ml) stimulation was determined
by ﬂuorescence microscopy (Hoechst stain/NF-κB assay). Visual image
quality control (QC) was performed with Metamorph (MDC) software
and automated quantitative image analysis by the use of the eCognition
(Deﬁniens) software. In addition, in RT-qPCR assays, induction of the
NF-κB target genes IL-8 and IL-6 after 30 and 60 min of TNF stimulation
was analyzed. QC of the screening data indicated that the screeningwas
performed successfully under technically sound conditions. The ranking
of candidate hit genes was done using the “redundant siRNA activity”
(RSA) methodology [55].Abbreviations list
AML aminoluciferin
Atx3 ataxin-3
CK2 casein-kinase-2
CD catalytic domain
CSN COP9 signalosome
COMMD1 copper metabolism Murr1 domain-containing protein 1
Cul cullin
CRL Cul-RING-Ub-ligase
CHX cycloheximide
EloB elongin B
DUB deubiquitinase
FL full length
HMW high molecular weight
IP immunoprecipitation
IB immunoblot
IκB inhibitor of NF-κB
JAMM/MPN+ motif JAB1/MPN/MOV34 motif
LMB leptomycin B
NEM N-ethylmaleimide
NF-κB nuclear factor kappa B
OPT ortho-phenanthroline
OTU1 otubain-1
Ub ubiquitin
UCH Ub c-terminal hydrolase
Ub-E3 Ub ligase
UPS Ub proteasome system
USP Ub-speciﬁc peptidase
VS vinylsulfone
VME vinylmethylester
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